↓ Skip to main content

Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review

Overview of attention for article published in BMC Cancer, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review
Published in
BMC Cancer, March 2022
DOI 10.1186/s12885-021-09145-0
Pubmed ID
Authors

Eveline Daetwyler, Mario Bargetzi, Maria Otth, Katrin Scheinemann

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 14%
Student > Bachelor 3 11%
Unspecified 1 4%
Lecturer 1 4%
Student > Ph. D. Student 1 4%
Other 1 4%
Unknown 17 61%
Readers by discipline Count As %
Medicine and Dentistry 4 14%
Biochemistry, Genetics and Molecular Biology 2 7%
Nursing and Health Professions 2 7%
Computer Science 2 7%
Psychology 2 7%
Other 1 4%
Unknown 15 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2022.
All research outputs
#14,427,926
of 23,577,654 outputs
Outputs from BMC Cancer
#3,305
of 8,530 outputs
Outputs of similar age
#209,902
of 444,114 outputs
Outputs of similar age from BMC Cancer
#59
of 267 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,530 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,114 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 267 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.